37115-45-0Relevant articles and documents
Expression and characterization of cynomolgus monkey cytochrome cyp3a4 in a novel human embryonic kidney cell-based mammalian systems
Selvakumar, Sindhuja,Bhutani, Priyadeep,Ghosh, Kaushik,Krishnamurthy, Prasad,Kallipatti, Sanjith,Selvam, Sabariya,Ramarao, Manjunath,Mandlekar, Sandhya,Sinz, Michael W.,Rodrigues, A. David,Subramanian, Murali
, p. 369 - 376 (2014)
Cynomolgus monkeys are a commonly used species in preclinical drug discovery, and have high genetic similarity to humans, especially for the drug-metabolizing cytochrome P450s. However, species differences are frequently observed in the metabolism of drug
Triazolobenzodiazepine derivatives
-
, (2008/06/13)
Compounds of the class of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-lower alkanols, and their ethers and esters, 1-(fluoro-lower alkyl)-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines and the 5-oxides and pharmaceutically acceptable acid addition salts thereof have central depressant properties, in particular antiaggressive and anticonvulsant actions, and are active ingredients for pharmaceutical compositions. Specific embodients are 6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-methanol and 1-(fluoromethyl)6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine.